(Q37343365)

19 August 2017

1 reference

title

Psychopharmacological treatment of oppositional defiant disorder (English)

1 reference

oppositional defiant disorder

19 August 2017

main subject

0 references

author name string

Atilla Turgay

series ordinal

1

1 reference

19 August 2017

publication date

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

23

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

1-17

1 reference

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

Effect of dextroamphetamine on children. Studies on subjects with learning disabilities and school behavior problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

Hyperactive children treated with stimulants. Is cognitive training a useful adjunct?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0023210-200923010-00001

On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in child psychopathology

21 January 2018

1 reference

12 December 2020

Pharmacological management of agitation in emergency settings

1 reference

12 December 2020

An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder

1 reference

12 December 2020

Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation

1 reference

12 December 2020

Parent management training: evidence, outcomes, and issues

1 reference

12 December 2020

Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds

1 reference

12 December 2020

Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study

1 reference

12 December 2020

The pharmacologic treatment of child and adolescent depression.

1 reference

12 December 2020

A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder

1 reference

12 December 2020

Clonidine in child and adolescent psychiatry

1 reference

12 December 2020

Remission versus response as the goal of therapy in ADHD: a new standard for the field?

1 reference

12 December 2020

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

12 December 2020

Major Depression with ADHD: In Children and Adolescents

1 reference

12 December 2020

A double-blind pilot study of risperidone in the treatment of conduct disorder

1 reference

12 December 2020

Efficacy of Parent-Child Interaction Therapy: Interim Report of a Randomized Trial with Short-Term Maintenance

1 reference

12 December 2020

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

1 reference

12 December 2020

NIMH Collaborative Multisite Multimodal Treatment Study of Children with ADHD: I. Background and Rationale

1 reference

12 December 2020

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

1 reference

12 December 2020

Lowering the burden of suffering from child psychiatric disorder: trade-offs among clinical, targeted, and universal interventions.

1 reference

12 December 2020

The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate

1 reference

12 December 2020

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

1 reference

12 December 2020

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Oppositional defiant and conduct disorders: issues to be resolved for DSM-IV.

1 reference

12 December 2020

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

1 reference

12 December 2020

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

12 December 2020

Videotape reliability of the third revised edition of the K-SADS

1 reference

12 December 2020

Suspected adverse methylphenidate-imipramine interactions in children

1 reference

12 December 2020

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

12 December 2020

Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

1 reference

12 December 2020

Non-stimulant medications in the treatment of ADHD.

1 reference

12 December 2020

The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity

1 reference

12 December 2020

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

1 reference

12 December 2020

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities

1 reference

12 December 2020

Conduct disorder: long-term outcomes and intervention effectiveness

1 reference

12 December 2020

Toward a transactional conceptualization of oppositional defiant disorder: implications for assessment and treatment

1 reference

12 December 2020

Anxiety, inhibition, and conduct disorder in children: I. Relations to social impairment.

1 reference

12 December 2020

Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder

1 reference

12 December 2020

Aggression and disruptive behavior disorders in children and adolescents

1 reference

12 December 2020

Effectiveness of collaborative problem solving in affectively dysregulated children with oppositional-defiant disorder: initial findings

1 reference

12 December 2020

Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study

1 reference

12 December 2020

DSM-III disorders from age 11 to age 15 years

1 reference

12 December 2020

Social-cognitive processes in preschool boys with and without oppositional defiant disorder

1 reference

12 December 2020

The Nisonger CBRF: a child behavior rating form for children with developmental disabilities

1 reference

12 December 2020

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

1 reference

12 December 2020

Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study

1 reference

12 December 2020

Effective psychosocial treatments of conduct-disordered children and adolescents: 29 years, 82 studies, and 5,272 kids

1 reference

12 December 2020

The reliability and validity of the Oppositional Defiant Behavior Inventory.

1 reference

12 December 2020

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Treatment of aggressive children with clonidine: results of an open pilot study

1 reference

12 December 2020

Source-specific oppositional defiant disorder: comorbidity and risk factors in referred elementary schoolboys.

1 reference

12 December 2020

Four-year longitudinal study of conduct disorder in boys: patterns and predictors of persistence

1 reference

12 December 2020

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

1 reference

12 December 2020

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

12 December 2020

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Pharmacotherapy of aggression in children and adolescents: efficacy and effect size

1 reference

12 December 2020

Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients

1 reference

12 December 2020

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

1 reference

12 December 2020

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

12 December 2020

Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial

1 reference

12 December 2020

Bupropion effects in attention deficit and conduct disorders

1 reference

12 December 2020

Lithium treatment of conduct disorders in adolescents

1 reference

12 December 2020

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

1 reference

12 December 2020

Differentiating psychiatrically disturbed children on the basis of a structured interview

1 reference

12 December 2020

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

Sudden death in children receiving Norpramin: a review of three reported cases and commentary

1 reference

12 December 2020

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

12 December 2020

10.2165/0023210-200923010-00001

Identifiers

DOI

1 reference

release_cxufzbu6jzhmjkv6chko7nksmu

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cxufzbu6jzhmjkv6chko7nksmu

24 November 2022

mapped directly with Wikidata item

1 reference